CT and MR for brain tumor implant therapy using CF-252 neutrons

  title={CT and MR for brain tumor implant therapy using CF-252 neutrons},
  author={Yosh Maruyama and Hong W. Chin and Anne B. Young and Joseph L. Beach and Phillip A. Tibbs and Sidney Goldstein and William R. Markesbery},
  journal={Journal of Neuro-Oncology},
Magnetic resonance (MR) imaging of the brain allows very effective localization of tumor in brain, visualization of brain reaction to tumor, peritumoral edema, as well as destruction of normal anatomy and spread of tumor. MR readily imaged the brain in multiple views allowing three dimensional (3D) evaluation and more precise localization of tumor in the depths of the brain. It also assessed the extent of tumor infiltration away from the primary site. In an ongoing study of Cf-252 neutron… 
1 Citations

Preliminary Results of Interstitial <SUP>192</SUP>Ir Brachytherapy for Malignant Gliomas

The results suggest that brachy therapy is not curative but prolonged the median survival time by 6 months and the most commonly observed CT finding was central low density after interstitial brachytherapy.



A tumor/normal tissue advantage for low dose rate neutron brachytherapy.

Interstitial brachytherapy of primary brain tumors. Preliminary report.

Ten patients harboring inaccessible, slow-growing or recurrent malignant primary brain tumors were treated by the stereotaxic implantation of a radionuclide seed -- iridium-192 (192Ir) or gold-198

Fast neutron beam radiotherapy of glioblastoma multiforme.

The deaths of patients with glioblastoma multiforme treated with fast neutron beam irradiation of the whole brain appear to be related to unexplained causes other than progressive growth of tumor.

Cf-252 neutron brachytherapy: an advance for bulky localized cancer therapy

Cf-252 brachytherapy will clear the local manifestations of recurrent or metastatic tumors or advanced stages of primary tumors and therefore in conjunction with other adjuvant therapies offers much more effective tumor control and palliation than present conventional therapy.

Interstitial 252Cf neutron therapy for glioblastoma multiforme*

It became clear that these tumors are of large size and bulk, produce marked adjacent brain edema, and require individualized implant therapy as well as high-dose external beam irradiation if response is to occur.

Fast neutrons compared with megavoltage x-rays in the treatment of patients with supratentorial glioblastoma: a controlled pilot study.

Scheduling of hypoxic-tumor therapy using neutron brachytherapy.

Findings indicate that traditional concepts developed for the use of conventional low-LET therapy may need to be altered to use neutrons for therapy and to achieve improved local control of advanced cancers.

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas.

Survival response of malignant gliomas to radiotherapy with or without BCNU or methyl-CCNU chemotherapy at the University of Kentucky Medical Center.

The best survival rate in this study was obtained in patients who received methyl-CCNU with irradiation, and the duration of survival was increased to nearly two times that of the radiotherapy group and to six times of the surgery only group.

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

It is suggested that it is best to use radiotherapy in the post-surgical treatment of malignant glioma and to continue the search for an effective chemotherapeutic regimen to use in addition to radiotherapy.